INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Building the Blueprint-CRC]( "Building the Blueprint: What Psychedelic Trials Need Now")
Building the Blueprint: What Psychedelic Trials Need NowDiscover how leading experts are addressing recent regulatory reviews to shape the next phase of psychedelic clinical research.
-
![Medable CLSE thumbnail]( "The Future Of Patient Experience: Lessons From GLP-1 Studies")
The Future Of Patient Experience: Lessons From GLP-1 StudiesImprove adherence, retention, and data quality in GLP-1 and cardiometabolic trials through connected digital tools, real-time symptom tracking, caregiver support, and AI-assisted review.
-
![GettyImages-1397344064 Alzheimers]( "Addressing Trial Design Hurdles Across Alzheimer's Disease Stages")
Addressing Trial Design Hurdles Across Alzheimer's Disease StagesExplore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.
-
![GettyImages-1296723604 CRO turnover training]( "Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints")
Key Risk Areas that Can Derail Clinical Trials with Ocular EndpointsBy embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.
-
Adaptive Clinical Trials: Innovation With Hidden Challenges5/8/2026
Adaptive trial designs offer faster results and better patient care, but only if site infrastructure can keep up with the operational complexity of these highly flexible research models.
-
Harness An Adept IRB's Expertise To Streamline Study Design10/2/2026
An Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.
-
Obesity Clinical Research: Patient Recruitment Challenges1/15/2026
Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.
-
Improving The Patient Experience In Clinical Research2/6/2025
To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Patient- doctor- GettyImages-2155775525]( "Therapeutic Experience: Supporting Recruitment And Retention")
CSS offers customized patient recruitment and retention solutions across the globe, ensuring successful enrollment for clinical trials across various therapeutic areas.
-
![New Anti-Cancer Drug Shows Promising Results With Low Toxicity]( "Bold Thinking Overcomes Oncology Clinical Development Challenges")
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.
-
![GettyImages-1352603244-laptop-man-typing-technology-office]( "User Acceptance Testing (UAT): Keeping Trials On Track")
Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.
-
![meeting]( "Get It Right The First Time: Strategic Clinical Development")
Start early and get it right the first time. Course correct with a changing landscape. Overcome obstacles within clinical development. Collaborate with the best strategists and problem-solvers in clinical development.
-
![GettyImages-1220710526 lab, research]( "Clinical Research Consulting Services, Simplified")
Expert Support for Clinical Research and Research Administration
